Literature DB >> 10766332

Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands.

E Kiss1, E Garribba, G Micera, T Kiss, H Sakurai.   

Abstract

In order to assess the role of the low molecular mass bioligands of blood serum in vanadium binding, a study was made of the interactions of the complexes formed in the VO(IV)-picolinic acid and VO(IV)-6-methylpicolinic acid systems with various low molecular mass constituents of blood serum, such as oxalate, lactate, citrate and phosphate. The speciation of VO(IV) in these ternary systems and also in the binary VO(IV)-picolinic acid and VO(IV)-6-methylpicolinic acid systems was studied by pH-potentiometry at 25 degrees C and at an ionic strength I = 0.2 M (KCl). The binding modes of the complexes formed were determined by spectral (electronic absorption and EPR) methods. Picolinic acid and 6-methylpicolinic acid were found to form mono and bis complexes through the pyridine nitrogen and carboxylate oxygen, but the presence of the methyl group in 6-methylpicolinic acid surprisingly decreases the stability of its complexes significantly. The results obtained on the ternary systems reveal that mixed ligand complex formation is favoured in these systems, especially with citrate, and must therefore be taken into account in the speciation description of VO(IV) in blood serum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766332     DOI: 10.1016/s0162-0134(99)00215-9

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Binding of V(IV)O²⁺ to the Fe binding sites of human serum transferrin. A theoretical study.

Authors:  Gonçalo C Justino; Eugenio Garribba; João Costa Pessoa
Journal:  J Biol Inorg Chem       Date:  2013-10       Impact factor: 3.358

2.  A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds.

Authors:  Daniele Sanna; Péter Buglyó; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2010-03-26       Impact factor: 3.358

3.  Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.

Authors:  Kenji Kawabe; Takahiro Sasagawa; Yutaka Yoshikawa; Akio Ichimura; Katsumi Kumekawa; Naohisa Yanagihara; Toshikazu Takino; Hiromu Sakurai; Yoshitane Kojima
Journal:  J Biol Inorg Chem       Date:  2003-10-09       Impact factor: 3.358

4.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

5.  ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.

Authors:  Valeria Ugone; Daniele Sanna; Giuseppe Sciortino; Debbie C Crans; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-06-25       Impact factor: 5.165

Review 6.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.